ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...

The healthcare sector is an ideal place for long-term investors to focus their attention, in my view. You won't need a ...

According to Abbott, there is a pressing need for a continuous glucose-ketone monitor for individuals who are at higher risk of developing ketoacidosis.

An all-inclusive approach to diabetes management becomes key—one that includes staying active indoors, eating mindfully, and keeping up with glucose monitoring ... CGM devices like FreeStyle Libre ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

For patients with T2D, disparities in CGM prescriptions are seen by language preference, with less access for adult patients with non-English language preferences.

Efficient blood sugar control plays a major role in preventing diabetes, a disease affecting millions around the world. Detecting problems early, though, has always been tough.

After a meal some people experience high spikes in blood sugar followed by a crashing low. The dips can cause fatigue, moodiness and lead to overeating. Learning how to manage your blood sugar can ...

I paired my Oura ring with Dexcom's Stelo AI-powered CGM to track my glucose. Here's what I learned about my eating habits.